🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 8 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/04/2025 54,09 56,34 53,23 54,42 -0,38% 5,75% 2.215.700
14/04/2025 53,34 54,64 51,39 54,63 +7,05% 6,09% 2.310.500
11/04/2025 51,22 51,80 49,09 51,03 +1,43% 5,29% 4.036.600
10/04/2025 53,34 54,47 49,86 50,31 -9,60% 8,64% 2.905.100
09/04/2025 48,55 57,70 48,01 55,65 +12,88% 19,96% 4.270.400
08/04/2025 53,99 55,36 48,94 49,30 -5,92% 11,89% 3.550.200
07/04/2025 51,59 55,17 50,61 52,40 -3,73% 8,84% 4.155.800
04/04/2025 59,22 59,45 54,26 54,43 -7,13% 8,76% 4.577.400
03/04/2025 57,22 60,24 57,14 58,61 -6,18% 5,42% 3.759.400
02/04/2025 61,69 64,22 60,70 62,47 +0,90% 5,71% 3.804.900
01/04/2025 64,37 65,69 61,53 61,91 -2,99% 6,46% 3.549.000
31/03/2025 65,90 67,47 62,50 63,82 -9,36% 7,54% 4.635.400
28/03/2025 71,88 72,05 69,81 70,41 -1,95% 3,12% 984.500
27/03/2025 72,98 73,95 71,25 71,81 -1,47% 3,70% 1.364.900
26/03/2025 73,88 74,40 70,91 72,88 -0,99% 4,72% 1.387.300
25/03/2025 76,13 76,26 72,17 73,61 -3,56% 5,37% 1.304.100
24/03/2025 74,67 76,67 74,44 76,33 +3,01% 2,99% 1.876.100
21/03/2025 73,32 75,50 73,05 74,10 +0,88% 3,34% 2.592.500
20/03/2025 80,18 80,26 73,06 73,45 -8,15% 8,98% 3.593.100
19/03/2025 75,18 80,98 75,13 79,97 +8,74% 7,78% 5.039.900
18/03/2025 78,61 81,87 73,06 73,54 -27,44% 11,21% 13.410.900
17/03/2025 97,35 103,32 97,35 101,35 +4,28% 6,13% 925.400
14/03/2025 99,00 100,00 97,06 97,19 -1,20% 2,97% 874.100
13/03/2025 99,65 100,01 97,11 98,37 -1,40% 2,91% 736.600
12/03/2025 101,72 102,40 99,02 99,77 -0,93% 3,32% 756.300
11/03/2025 99,16 101,56 97,91 100,71 +1,02% 3,68% 1.019.700
10/03/2025 101,84 102,15 98,82 99,69 -3,24% 3,27% 1.639.200
07/03/2025 104,02 104,85 102,00 103,03 -2,40% 2,74% 1.160.000
06/03/2025 106,79 107,23 104,39 105,56 -1,96% 2,66% 889.000
05/03/2025 102,94 107,77 102,94 107,67 +4,68% 4,69% 1.958.700